Lactobacillus plantarum lactose permease deletion mutant strain delta lac s1 delta lac s2 and application thereof
By knocking out the lactose permeases LacS1 and LacS2 in Lactobacillus plantarum WCFS1, the ΔlacS1ΔlacS2 mutant strain was constructed, which solved the problem of impurities in the purification of galactooligosaccharides and human milk oligosaccharides, and achieved efficient and low-cost purification results.
Patent Information
- Application Number
- CN202311152936.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-09-07
- Publication Date
- 2026-11-10
- Estimated Expiration
- 2043-09-07
AI Technical Summary
In the existing technology, the synthetic products of galactooligosaccharides and human milk oligosaccharides contain a large number of miscellaneous sugar components, which makes purification difficult. Existing purification methods are costly and do not produce high purity, thus limiting the development and application of the products.
By knocking out the lactose permeases LacS1 and LacS2 in Lactobacillus plantarum WCFS1, a lactose permease-deficient mutant strain ΔlacS1ΔlacS2 was constructed. This mutant strain was used to purify galactooligosaccharides and human milk oligosaccharides.
This method achieves efficient purification of galactooligosaccharides and human milk oligosaccharides, reducing operating costs and improving product purity.
Smart Images

Figure CN117343887B_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of biotechnology, specifically to a lactose permease-deficient mutant strain ΔlacS1ΔlacS2 of Lactobacillus plantarum and its applications. Background Technology
[0002] Lactobacillus plantarum is an important probiotic frequently used for fermentation of lactose-rich substrates. Lactobacillus plantarum WCFS1 exhibits a strong lactose metabolism capacity. The lactose metabolism capacity of probiotics primarily relies on lactose permease (LacS), which transports lactose into the cell membrane, where it is then hydrolyzed into galactose and glucose by β-galactosidase, thus playing a role in lactose metabolism.
[0003] Galacto-oligosaccharide (GOS) is a mixed heterogeneous sugar formed by linking 1 to 7 galactose groups on the galactose side of the lactose molecule via β-glycosidic bonds. As a novel functional prebiotic, GOS has functions such as promoting the proliferation of intestinal bifidobacteria, improving the absorption of mineral elements, improving lipid metabolism, and preventing and treating constipation. The enzymatic synthesis of GOS using safe and efficient β-D-galactosidase has attracted widespread attention in recent years.
[0004] Breast milk is currently considered the best source of nutrition for infants and young children. The most important difference between breast milk and cow's milk lies in the different types and structures of oligosaccharides it contains. Human milk oligosaccharides (HMOs) are important oligosaccharides found only in breast milk. They are the third largest nutrient in breast milk after fat and lactose, and play an irreplaceable role in promoting the growth of intestinal flora, improving the function of the immune system, and promoting brain development in infants. To date, there are various methods for extracting or synthesizing HMOs. Among them, biosynthesis is often used to synthesize various HMOs because it does not use toxic reagents and is convenient for large-scale production.
[0005] In the synthesis of galactooligosaccharides (GOS) or human milk oligosaccharides, the synthesized products still contain a large amount of miscellaneous sugars such as glucose, galactose, and lactose. These miscellaneous sugars mask the functionality of GOS and human milk oligosaccharides, restricting the development of related products and their application in the market. Therefore, in the production of GOS or human milk oligosaccharides, the purification of downstream fermentation products is a key factor limiting production. Currently, the main separation and purification technologies for GOS and human milk oligosaccharides include ion exchange resin methods, chromatographic column methods, and nanofiltration membrane methods. However, these chemical methods have disadvantages such as expensive equipment and high operating costs, and the final extracted GOS or human milk oligosaccharide products still cannot achieve satisfactory purity. Summary of the Invention
[0006] To address the shortcomings of existing technologies, this invention provides a *Lactobacillus plantarum* lactose permease-deficient mutant strain ΔlacS1ΔlacS2 and its applications. A *Lactobacillus plantarum* lactose permease LacS1 and LacS2 mutant strain was obtained through gene knockout. This mutant strain can still utilize lactose, glucose, and galactose for growth, but cannot utilize galactooligosaccharides and human milk oligosaccharides. This strain can be used for the purification of prebiotics such as galactooligosaccharides and human milk oligosaccharides.
[0007] The technical solution of this invention is as follows:
[0008] A *Lactobacillus plantarum* lactose permease-deficient mutant strain ΔlacS1ΔlacS2, which lacks the lactose permease-encoding genes lacS1 and lacS2 from *Lactobacillus plantarum* WCFS1; wherein the nucleotide sequence of lacS1 is shown in SEQ ID NO.1, and the nucleotide sequence of lacS2 is shown in SEQ ID NO.2.
[0009] We studied the *Lactobacillus plantarum* strain WCFS1 and discovered for the first time that it contains two enzymes involved in lactose substrate transport. To investigate the specific biological activities of these two enzymes, we planned to knock out their encoding genes and verify the utilization effect of the knockout mutants on various sugars. Our research found that these two enzymes play an indispensable role in the utilization of galactooligosaccharides and human milk oligosaccharides. We named the two enzymes lactose permease LacS1 and lactose permease LacS2, respectively, and their encoding genes lacS1 and lacS2, respectively. The amino acid sequence of lactose permease LacS1 is shown in SEQ ID NO.15, and the amino acid sequence of lactose permease LacS2 is shown in SEQ ID NO.16.
[0010] Preferably, the method for constructing the *Lactobacillus plantarum* lactose permease-deficient mutant strains ΔlacS1 and ΔlacS2 includes the following steps:
[0011] (1) Using temperature-sensitive plasmid pG + host9 amplifies, fuses and ligates the upstream and downstream homologous arms of the target genes lacS1 and lacS2 into the plasmid to obtain the recombinant plasmid;
[0012] (2) Electroporate the recombinant plasmid from step (1) into Lactobacillus plantarum WCFS1 to knock out the gene, and obtain the knockout mutant strain;
[0013] (3) The knockout status of the mutant strain in step (2) was verified by PCR and sequencing technology, and the lactose permease-deficient mutant strains △lacS1△lacS2 of Lactobacillus plantarum were obtained.
[0014] Preferably, the primers used for amplifying the upstream homologous arm of lacS1 in step (1) are lacS1-Up-F and lacS1-Up-R, and their sequences are shown in SEQ ID NO.3 and SEQ ID NO.4, respectively; the primers used for amplifying the downstream homologous arm of lacS1 are lacS1-Down-F and lacS1-Down-R, and their sequences are shown in SEQ ID NO.5 and SEQ ID NO.6, respectively.
[0015] Preferably, the primers used for amplifying the upstream homologous arm of lacS2 in step (1) are lacS2-Up-F and lacS2-Up-R, and their sequences are shown in SEQ ID NO.7 and SEQ ID NO.8, respectively; the primers used for amplifying the downstream homologous arm of lacS2 are lacS2-Down-F and lacS2-Down-R, and their sequences are shown in SEQ ID NO.9 and SEQ ID NO.10, respectively.
[0016] Preferably, the fusion method in step (1) is overlap extension PCR.
[0017] Preferably, the primers used for PCR verification of lacS1 knockout in step (3) are lacS1-Test-F and lacS1-Test-R, and their sequences are shown in SEQ ID NO.11 and SEQ ID NO.12, respectively.
[0018] Preferably, the primers used for PCR verification of lacS2 knockout in step (3) are lacS2-Test-F and lacS2-Test-R; their sequences are shown in SEQ ID NO.13 and SEQ ID NO.14, respectively.
[0019] Application of the *Lactobacillus plantarum* lactose permease-deficient mutant strains ΔlacS1 and ΔlacS2 in prebiotic purification.
[0020] Preferably, the prebiotic is galactooligosaccharide or human milk oligosaccharide.
[0021] The application of genes lacS1 and / or lacS2 in glucose metabolism, wherein the nucleotide sequence of lacS1 is shown in SEQ ID NO.1 and the nucleotide sequence of lacS2 is shown in SEQ ID NO.2.
[0022] Preferably, the application of genes lacS1 and / or lacS2 in sugar metabolism is achieved by knocking out lacS1 and / or lacS2 in a strain to prepare engineered bacteria, which are then used to purify galactooligosaccharides or human milk oligosaccharides.
[0023] Beneficial effects:
[0024] This invention is the first to discover two lactose permeases, LacS1 and LacS2, present in *Lactobacillus plantarum* WCFS1, and provides a *Lactobacillus plantarum* lactose permease-deficient mutant strain ΔlacS1ΔlacS2, which lacks both lactose permeases LacS1 and LacS2. This mutant strain can still grow using lactose, glucose, and galactose, but cannot use galactooligosaccharides and human milk oligosaccharides. This strain can be used for the purification of prebiotics such as galactooligosaccharides and human milk oligosaccharides, which is convenient, effective, and low in operating costs. Attached Figure Description
[0025] Figure 1 PCR and sequencing results to validate lacS1 and lacS2 knockout status;
[0026] Figure 2 The growth of Lactobacillus plantarum WCFS1 and ΔlacS1ΔlacS2 in MRS-glucose medium (where white columns represent Lactobacillus plantarum WCFS1 and gray columns represent ΔlacS1ΔlacS2).
[0027] Figure 3 The growth of Lactobacillus plantarum WCFS1 and ΔlacS1ΔlacS2 in MRS-lactose medium (where white columns represent Lactobacillus plantarum WCFS1 and gray columns represent ΔlacS1ΔlacS2).
[0028] Figure 4 The growth of Lactobacillus plantarum WCFS1 and ΔlacS1ΔlacS2 in MRS-galactose medium (where white columns represent Lactobacillus plantarum WCFS1 and gray columns represent ΔlacS1ΔlacS2).
[0029] Figure 5 The growth of Lactobacillus plantarum WCFS1 and ΔlacS1ΔlacS2 in MRS-galacto-oligosaccharide medium (where white columns represent Lactobacillus plantarum WCFS1 and gray columns represent ΔlacS1ΔlacS2).
[0030] Figure 6The growth of *Lactobacillus plantarum* WCFS1 and ΔlacS1ΔlacS2 in MRS-2'-fucosylated lactose medium (where white columns represent *Lactobacillus plantarum* WCFS1 and gray columns represent ΔlacS1ΔlacS2). Detailed Implementation
[0031] The following description is based on specific embodiments:
[0032] Explanation of the source of experimental materials:
[0033] Lactobacillus plantarum WCFS1: Purchased from Guangdong Huankai Microbial Technology Co., Ltd.;
[0034] Temperature-sensitive plasmid pG + host9: Purchased from BioVector NTCC Plasmid Vector Bacterial Strain Cell Protein Antibody Gene Preservation Center;
[0035] Lactose, glucose, and galactose were all purchased from Shanghai Sangon Biotech Co., Ltd.
[0036] Galacto-oligosaccharides (approximately 70% purity): purchased from Shanghai Yuanye Biotechnology Co., Ltd.
[0037] Galacto-oligosaccharides (approximately 99% purity): purchased from Beijing Coolplay Technology Co., Ltd.
[0038] 2'-Fucose-based lactose (approximately 90% purity): Purchased from Shanghai Huicheng Biotechnology Co., Ltd.
[0039] 2'-Fucose-based lactose (purity approximately 99%): Purchased from Xi'an Youkangfulai Biotechnology Co., Ltd.
[0040] Example 1:
[0041] Construction of Lactobacillus plantarum lactose permease deletion mutants ΔlacS1 and ΔlacS2
[0042] (1) Using temperature-sensitive plasmid pG +Host9 amplified, fused, and ligated the upstream and downstream homologous arms of the target genes lacS1 and lacS2 into plasmids to obtain recombinant plasmids. The primers used for amplifying the upstream homologous arm of lacS1 were lacS1-Up-F and lacS1-Up-R, with sequences shown in SEQ ID NO.3 and SEQ ID NO.4, respectively; the primers used for amplifying the downstream homologous arm of lacS1 were lacS1-Down-F and lacS1-Down-R, with sequences shown in SEQ ID NO.5 and SEQ ID NO.6, respectively; the primers used for amplifying the upstream homologous arm of lacS2 were lacS2-Up-F and lacS2-Up-R, with sequences shown in SEQ ID NO.7 and SEQ ID NO.8, respectively; and the primers used for amplifying the downstream homologous arm of lacS2 were lacS2-Down-F and lacS2-Down-R, with sequences shown in SEQ ID NO.9 and SEQ ID NO.10, respectively.
[0043] (2) Electroporate the recombinant plasmid from step (1) into Lactobacillus plantarum WCFS1 to knock out the gene, and obtain the knockout mutant strain;
[0044] (3) The knockout status of the mutant strain in step (2) was verified by PCR and sequencing technology. Using the genomic DNA of the mutant strain as a template, the primers used for PCR verification of lacS1 knockout were lacS1-Test-F and lacS1-Test-R, and their sequences are shown in SEQ ID NO.11 and SEQ ID NO.12, respectively. The primers used for PCR verification of lacS2 knockout were lacS2-Test-F and lacS2-Test-R, and their sequences are shown in SEQ ID NO.13 and SEQ ID NO.14, respectively.
[0045] PCR and sequencing results validating lacS1 and lacS2 knockout are as follows: Figure 1 As shown; where, Figure 1 Figure A shows the PCR results used to verify lacS1 knockout. Figure 1 Figure B shows the sequencing results that verify the lacS1 knockout status; Figure 1 Figure C shows the PCR results used to verify lacS2 knockout. Figure 1 The D-plot shows the sequencing results used to verify the lacS2 knockout.
[0046] Depend on Figure 1The PCR amplification products were all 3000 bp in size, consistent with the expected theoretical value. The sequencing results also showed that the gene was successfully knocked out, with the arrow indicating the location of the gene knockout. This indicates that the *Lactobacillus plantarum* lactose permease LacS1 and LacS2 deletion mutant strains were successfully constructed and named "△lacS1△lacS2".
[0047] Experimental Example 1:
[0048] (1) Glucose utilization of ΔlacS1 and ΔlacS2
[0049] Lactobacillus plantarum WCFS1 and ΔlacS1ΔlacS2 were inoculated into MRS-glucose medium with glucose as the sole carbon source and cultured statically at 37°C. The growth of the strains is shown in the figure. Figure 2 As shown;
[0050] Depend on Figure 2 It was found that *Lactobacillus plantarum* WCFS1 and ΔlacS1 and ΔlacS2 could grow well in MRS-glucose medium, with an OD of 12 hours. 600 The average values were 9.1 and 8.7, respectively, for 24-hour OD. 600 The average values were 11.8 and 10.9, respectively; the results indicate that ΔlacS1 and ΔlacS2 can still utilize glucose.
[0051] (2) Lactose utilization of △lacS1 and △lacS2
[0052] Lactobacillus plantarum WCFS1 and ΔlacS1ΔlacS2 were inoculated into MRS-lactose medium with lactose as the sole carbon source and cultured statically at 37°C. The growth of the strains is shown in the figure. Figure 3 As shown;
[0053] Depend on Figure 3 It was found that *Lactobacillus plantarum* WCFS1 and ΔlacS1 and ΔlacS2 could grow well in MRS-lactose medium, with an OD of 12 hours. 600 The average values were 8.4 and 8.1, respectively, for 24-hour OD. 600 The average values were 12.4 and 11.8, respectively; the results indicate that ΔlacS1 and ΔlacS2 can still utilize lactose.
[0054] (3) Galactose utilization of △lacS1 and △lacS2
[0055] Lactobacillus plantarum WCFS1 and ΔlacS1ΔlacS2 were inoculated into MRS-galactose medium with galactose as the sole carbon source and cultured statically at 37°C. The growth of the strains is shown in the figure. Figure 4 As shown;
[0056] Depend on Figure 4 It was found that *Lactobacillus plantarum* WCFS1 and ΔlacS1 and ΔlacS2 could grow well in MRS-galactose medium, with an OD of 12 hours. 600 The average values were 7.3 and 7.1, respectively, for 24-hour OD. 600 The average values were 9.8 and 8.9, respectively; the results indicate that ΔlacS1 and ΔlacS2 can still utilize galactose.
[0057] (4) Utilization of galactooligosaccharides in ΔlacS1 and ΔlacS2
[0058] Lactobacillus plantarum WCFS1 and ΔlacS1ΔlacS2 were inoculated into MRS-galacto-oligosaccharide medium with galacto-oligosaccharide (approximately 99% purity) as the sole carbon source and cultured statically at 37°C. The growth of the strains is shown below. Figure 5 As shown;
[0059] Depend on Figure 5 It was found that *Lactobacillus plantarum* WCFS1 can grow well in MRS-galacto-oligosaccharide medium, with OD values at 12 hours and 24 hours. 600 The average values were 5.4 and 6.7, respectively; however, ΔlacS1 and ΔlacS2 did not grow well in MRS-galacto-oligosaccharide medium, with OD values of 12 hours and 24 hours. 600 The average values were only 0.7 and 0.8, respectively; the results showed that ΔlacS1 and ΔlacS2 could not utilize galactooligosaccharides as well as Lactobacillus plantarum WCFS1.
[0060] (5) Utilization of human milk oligosaccharides in ΔlacS1 and ΔlacS2
[0061] Taking 2'-fucosyllactose as an example, *Lactobacillus plantarum* WCFS1 and ΔlacS1 and ΔlacS2 were inoculated into MRS-2'-fucosyllactose medium with 2'-fucosyllactose (purity approximately 99%) as the sole carbon source and cultured statically at 37°C. The growth of the strains is shown below. Figure 6 As shown;
[0062] Depend on Figure 6 It was found that *Lactobacillus plantarum* WCFS1 can grow well in MRS-2'-fucosylated lactose medium, with OD values at 12 hours and 24 hours. 600 The average values were 3.7 and 4.9, respectively; however, ΔlacS1 and ΔlacS2 did not grow well in MRS-2'-fucosylated lactose medium, with OD values at 12 hours and 24 hours being [missing data]. 600The average values were 0.4 and 0.6, respectively; the results showed that △lacS1 and △lacS2 were not as good at utilizing 2'-fucosylated lactose as Lactobacillus plantarum WCFS1.
[0063] The above experiments show that the mutant strains △lacS1 and △lacS2, which lack lactose permeases LacS1 and LacS2, are almost unable to utilize galac-oligosaccharides and human milk oligosaccharides compared to Lactobacillus plantarum WCFS1. This indicates that the lactose permeases LacS1 and LacS2 present in Lactobacillus plantarum WCFS1 play an indispensable role in the utilization of galac-oligosaccharides and human milk oligosaccharides.
[0064] Example 2:
[0065] Using ΔlacS1 and ΔlacS2 to improve the purity of galactooligosaccharides and human milk oligosaccharides (taking 2'-fucosylated lactose as an example).
[0066] (1) Take 1g each of galactooligosaccharide (purity about 70%) and 2'-fucosylated lactose (purity about 90%), dissolve them in 10mL of water respectively to prepare 10mL each of galactooligosaccharide solution and 2'-fucosylated lactose solution;
[0067] (2) Collect 10 mL each of Lactobacillus plantarum WCFS1 and ΔlacS1ΔlacS2 bacterial cultures that have been cultured to the logarithmic growth phase, centrifuge them separately to collect the precipitates, and resuspend the precipitates in 10 mL of galactooligosaccharide solution and 10 mL of 2'-fucosylated lactose solution respectively, and let them stand at 37°C for 24 h (treatment).
[0068] (3) The sugar content in the galactooligosaccharide and 2'-fucosylated lactose samples before and after treatment was detected by high performance liquid chromatography. The results are shown in Table 1 and Table 2 below, respectively.
[0069] Table 1. Changes in sugar content (%) of galactooligosaccharide samples before and after treatment
[0070]
[0071] As shown in Table 1, after treatment with Lactobacillus plantarum WCFS1, the content of galactooligosaccharides in the sample increased to 79%, which was slightly higher than before treatment. After treatment with ΔlacS1 and ΔlacS2, the contents of lactose, glucose, and galacose in the sample all decreased to below 0.5%. Moreover, after the above monosaccharides were utilized, the content of galactooligosaccharides in the sample increased from 71.02% to 99.29%. This indicates that the Lactose Permease Deficit Mutant ΔlacS1 and ΔlacS2 of Lactobacillus plantarum can effectively improve the purity of galactooligosaccharides.
[0072] Table 2.2' - Changes in sugar content (%) before and after fucoidosyl lactose sample treatment
[0073]
[0074] As shown in Table 2, after treatment with *Lactobacillus plantarum* WCFS1, the content of 2'-fucosylated lactose in the sample increased to 94.33%, a slight increase compared to before treatment. After treatment with ΔlacS1 and ΔlacS2, the contents of lactose, glucose, and galactose in the sample all decreased to below 0.3%, and after the above monosaccharides were utilized, the content of 2'-fucosylated lactose in the sample increased from 89.15% to 99.45%. This indicates that the *Lactobacillus plantarum* lactose permease-deficient mutant strains ΔlacS1 and ΔlacS2 can effectively improve the purity of 2'-fucosylated lactose.
[0075] In summary, this invention is the first to discover two lactose permeases, LacS1 and LacS2, present in Lactobacillus plantarum WCFS1, and provides a Lactobacillus plantarum lactose permease-deficient mutant strain ΔlacS1ΔlacS2. This strain can be used for the purification of prebiotics such as galactooligosaccharides and human milk oligosaccharides, which is convenient, effective, and low in operating costs.
Claims
1. Lactobacillus plantarum lactose permease-deficient mutant ΔlacS1ΔlacS2 Its application in prebiotic purification is characterized by, The ΔlacS1ΔlacS2 The gene encoding lactose permease in Lactobacillus plantarum WCFS1 is missing. lacS1 And lactose through enzyme-encoded genes lacS2 ; wherein, the lacS1 The nucleotide sequence is shown in SEQ ID NO.
1. lacS2 The nucleotide sequence is shown in SEQ ID NO.2; the prebiotic is a human milk oligosaccharide, and the human milk oligosaccharide is 2'-fucosylated lactose.
2. The application as described in claim 1, characterized in that, The construction method includes the following steps: (1) Using temperature-sensitive plasmid pG + host9, respectively target genes lacS1 and lacS2 The upstream and downstream homologous arms are amplified, fused, and ligated into the plasmid to obtain a recombinant plasmid. (2) Electroporate the recombinant plasmid from step (1) into Lactobacillus plantarum WCFS1 to knock out the gene, and obtain the knockout mutant strain; (3) The knockout status of the mutant strain in step (2) was verified by PCR and sequencing technology, and the lactose permease-deficient mutant strain of Lactobacillus plantarum was obtained. △lacS1△lacS2 .
3. The application as described in claim 2, characterized in that, In step (1) lacS1 The primers used for amplification of the upstream homologous arm were lacS1-Up-F and lacS1-Up-R, and their sequences are shown in SEQ ID NO.3 and SEQ ID NO.4, respectively. lacS1 The primers used for downstream homologous arm amplification were lacS1-Down-F and lacS1-Down-R, whose sequences are shown in SEQ ID NO.5 and SEQ ID NO.6, respectively.
4. The application as described in claim 2, characterized in that, In step (1) lacS2 The primers used for amplification of the upstream homologous arm were lacS2-Up-F and lacS2-Up-R, and their sequences are shown in SEQ ID NO.7 and SEQ ID NO.8, respectively. lacS2 The primers used for downstream homologous arm amplification were lacS2-Down-F and lacS2-Down-R, whose sequences are shown in SEQ ID NO.9 and SEQ ID NO.10, respectively.
5. The application as described in claim 2, characterized in that, PCR verification in step (3) lacS1 The primers used for the knockout were lacS1-Test-F and lacS1-Test-R, whose sequences are shown in SEQ ID NO.11 and SEQ ID NO.12, respectively.
6. The application as described in claim 2, characterized in that, PCR verification in step (3) lacS2 The primers used for the knockout were lacS2-Test-F and lacS2-Test-R; their sequences are shown in SEQ ID NO.13 and SEQ ID NO.14, respectively.
7. Genes lacS1 and genes lacS2 Its application in glucose metabolism is characterized by, The lacS1 The nucleotide sequence is shown in SEQ ID NO.
1. lacS2 The nucleotide sequence is shown in SEQ ID NO.
2. The application method is to use the strain... lacS1 and lacS2 The engineered bacteria were prepared after knockout, and the engineered bacteria were used to purify human milk oligosaccharides, wherein the human milk oligosaccharides were 2'-fucosylated lactose. The strain is Lactobacillus plantarum WCFS1.
Citation Information
Patent Citations
Method for isolation and purification of human oligosaccharide using lactose removal of immobilized Kluyveromyces lactis
KR1020190047787A
